Cite
HARVARD Citation
Fleseriu, M. et al. (2019). Long‐term efficacy and safety of once‐monthly pasireotide in Cushing's disease: A Phase III extension study. Clinical endocrinology. pp. 776-785. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fleseriu, M. et al. (2019). Long‐term efficacy and safety of once‐monthly pasireotide in Cushing's disease: A Phase III extension study. Clinical endocrinology. pp. 776-785. [Online].